Expiry of HIV Integrase Option Period with Tibotec
Half Year Report 31 December 2009
Avexa reports positive phase IIb 144 week data for HIV drug apricitabine
Avexa announces ATC phase III top line results
CEO's presentation to the 2009 AGM
Chairman's address to the 2009 AGM
Annual Report 2009
Full Year Statutory Accounts 30 June 2009
